220 related articles for article (PubMed ID: 28470471)
1. Expression and Activity of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Distal Lung Epithelial Cells In Vitro.
Nickel S; Selo MA; Fallack J; Clerkin CG; Huwer H; Schneider-Daum N; Lehr CM; Ehrhardt C
Pharm Res; 2017 Dec; 34(12):2477-2487. PubMed ID: 28470471
[TBL] [Abstract][Full Text] [Related]
2. Tobacco Smoke and Inhaled Drugs Alter Expression and Activity of Multidrug Resistance-Associated Protein-1 (MRP1) in Human Distal Lung Epithelial Cells
Selo MA; Delmas AS; Springer L; Zoufal V; Sake JA; Clerkin CG; Huwer H; Schneider-Daum N; Lehr CM; Nickel S; Langer O; Ehrhardt C
Front Bioeng Biotechnol; 2020; 8():1030. PubMed ID: 33015009
[TBL] [Abstract][Full Text] [Related]
3. The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier.
Salomon JJ; Muchitsch VE; Gausterer JC; Schwagerus E; Huwer H; Daum N; Lehr CM; Ehrhardt C
Mol Pharm; 2014 Mar; 11(3):995-1006. PubMed ID: 24524365
[TBL] [Abstract][Full Text] [Related]
4. Functional Evaluation of P-gp and Bcrp at the Murine Blood-Cerebrospinal Fluid Barrier.
Sun A; Wang J
Pharm Res; 2023 Nov; 40(11):2667-2675. PubMed ID: 37704894
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
[TBL] [Abstract][Full Text] [Related]
6. Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity.
Mishra J; Simonsen R; Kumar N
J Biol Chem; 2019 Nov; 294(48):18337-18348. PubMed ID: 31653704
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
8. Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3).
Paturi DK; Kwatra D; Ananthula HK; Pal D; Mitra AK
Int J Pharm; 2010 Jan; 384(1-2):32-8. PubMed ID: 19782742
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers.
Wright JA; Haslam IS; Coleman T; Simmons NL
Eur J Pharmacol; 2011 Dec; 672(1-3):70-6. PubMed ID: 22004608
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional analyses of breast cancer resistance protein in lung cancer.
Kawabata S; Oka M; Soda H; Shiozawa K; Nakatomi K; Tsurutani J; Nakamura Y; Doi S; Kitazaki T; Sugahara K; Yamada Y; Kamihira S; Kohno S
Clin Cancer Res; 2003 Aug; 9(8):3052-7. PubMed ID: 12912956
[TBL] [Abstract][Full Text] [Related]
11. Expression of BCRP/ABCG2 Protein in Invasive Breast Cancer and Response to Neoadjuvant Chemotherapy.
Zhang YS; Yang C; Han L; Liu L; Liu YJ
Oncol Res Treat; 2022; 45(3):94-101. PubMed ID: 34775385
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.
Ni Z; Bikadi Z; Cai X; Rosenberg MF; Mao Q
Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1100-9. PubMed ID: 20739628
[TBL] [Abstract][Full Text] [Related]
13. The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.
Rigalli JP; Scholz PN; Tocchetti GN; Ruiz ML; Weiss J
Eur J Nutr; 2019 Feb; 58(1):139-150. PubMed ID: 29101532
[TBL] [Abstract][Full Text] [Related]
14. Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP).
Engdahl E; van Schijndel MDM; Voulgaris D; Di Criscio M; Ramsbottom KA; Rigden DJ; Herland A; Rüegg J
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073890
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ABC Transporters in EpiAirway™, a Cellular Model of Normal Human Bronchial Epithelium.
Rotoli BM; Barilli A; Visigalli R; Ferrari F; Frati C; Lagrasta CA; Lascia MD; Riccardi B; Puccini P; Dall'Asta V
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32366035
[TBL] [Abstract][Full Text] [Related]
16. Drug Transporter Protein Quantification of Immortalized Human Lung Cell Lines Derived from Tracheobronchial Epithelial Cells (Calu-3 and BEAS2-B), Bronchiolar-Alveolar Cells (NCI-H292 and NCI-H441), and Alveolar Type II-like Cells (A549) by Liquid Chromatography-Tandem Mass Spectrometry.
Sakamoto A; Matsumaru T; Yamamura N; Suzuki S; Uchida Y; Tachikawa M; Terasaki T
J Pharm Sci; 2015 Sep; 104(9):3029-38. PubMed ID: 25690838
[TBL] [
